No Data
No Data
No Data
No Data
No Data
Express News | Neurosense Therapeutics: Study Expected to Reveal Safety of Primec in Ad, and Shed Light on Efficacy, Biological Activity of Combination Therapy
Moomoo 24/7Apr 22 08:34 ET
Express News | NeuroSense Shares Are Trading Higher After the Company Announced an Alzheimer's Drug Development Collaboration With Genetika+
Moomoo 24/7Apr 22 08:33 ET
Express News | Neurosense and Genetika+ Initiate Precision Medicine Collaboration Beginning With Ongoing Phase 2 Clinical Trial in Alzheimer's Disease
Moomoo 24/7Apr 22 08:30 ET
Express News | Neurosense Presents Positive Data Validating Phase 2B Topline Readout During Emerging Science Presentation at the American Academy of Neurology Annual Meeting
Moomoo 24/7Apr 18 08:30 ET
Express News | NeuroSense To Present PARADIGM Data At American Academy Of Neurology Annual Meeting
Moomoo 24/7Apr 12 08:36 ET
NeuroSense to Present PARADIGM Data at the American Academy of Neurology Annual Meeting April 16, 2024
NeuroSense Therapeutics Ltd. (Nasdaq: NRSN) ("NeuroSense"), a company developing novel treatments for severe neurodegenerative diseases, announces...
PR NewswireApr 12 08:30 ET
Jaguar8 : Super super like. I have genes of Alzheimer’s
TrytosaveabitOP Jaguar8: They need to go farther with the ( little blue pill ) studies! They have been some of the most impressive IMO!
Jaguar8 TrytosaveabitOP: I’ve read some literature about possible causes of Alzheimer’s which is not the amyloid plaque
Jaguar8 Jaguar8: Just trying to see how far they are pushing on this
TrytosaveabitOP Jaguar8: Exactly! That’s why I say much more with blue pill needs done! Preliminary research shows what you say and why Sildenafil could be the treatment
No Data
No Data